Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/AMRYT-PHARMA-PLC-66481723/news/The-Lancet-Diabetes-Endocrinology-veroffentlicht-positive-Ergebnisse-der-Phase-3-Studie-MPOWERED-37471634/?utm_source=whatsapp&utm_medium=social&utm_campaign=share